Proximal Tibial Open Wedge Osteotomy. A Clinical Prospective, Randomized RSA-trial.
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
In the treatment of osteoarthritis of the medial compartment of the knee, Open wedge high tibial osteotomy is a good choice of treatment for the young and active patient.
However it leaves an open gap which has to be filled with a bone substitute and requires stable fixation.
Hitherto the golden standard has been autograft taken from iliac crest but there are donorsite related problems and limited amount available.
Recently injectable and resorbable calciumphosphate-cements have been introduced and used with promising results in fractures of the distal radius, calcaneus and lateral tibial condyle.
These new cements seem to be a good alternative to other bone substitutes providing high initial strength that might promote early mobilisation; it resorbs and promotes osteoconduction securing safe healing.
The aim of the present study is to evaluate whether there is any difference in clinical outcome, correction, stability and healing in open-wedge osteotomies with three different bone substitutes: Autograft from iliac crest and the injectable calciumphosphate-cement Calcibon and as control a group with an empty gap.
Osteosynthesis is performed with the Dynafix® system (EBI) The investigation is performed as a randomised prospective clinical trial including 45 patients with a planned 2 years follow-up period.
Clinical outcome is evaluated with: Hospital of special surgery score, KOOS, SF 12 and Lysholm score.
Routine standing x-rays is performed. Stability is assessed with Roentgen Stereophotogrammetric Analysis (RSA) that provides the opportunity of exact 3-dimensional measuring of eventual loss of correction.
This combined with urine and serum bone-healing markers gives a very precise picture of the healing in the bone-gap.
To asses the cartilage of the knee MRI is performed and biochemical markers fore Collagen type II degradation are measured.
| Condition | Intervention | Phase |
|---|---|---|
|
Osteoarthritis, Knee |
Procedure: bonesubstitution (Calcibon, Iliac Crest Bonegraft, control) |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Proximal Tibial Open Wedge Osteotomy. Stability and Healing Evaluated in a Clinical Prospective, Randomized Trial Using RSA. |
- Migration in mm measured with RSA (Roentgen Stereometric Analysis) [ Time Frame: postoperative, at 3 month, 1 and 2 years ] [ Designated as safety issue: No ]
- Hip-Knee-Ankle axis [ Time Frame: 3 month, 1 and 2 years. ] [ Designated as safety issue: No ]
- MR of the knee [ Time Frame: 4 weeks preoperative, preoperative, at 1 and 2 years postoperative. ] [ Designated as safety issue: No ]
- Markers of chondral degradation [ Time Frame: preoperative, at 6 weeks, 3 month, 1 and 2 years postoperative ] [ Designated as safety issue: No ]
- Markers of bone synthesis and degradation [ Time Frame: preoperative, at 6 weeks, 3 month, 1 and 2 years postoperative ] [ Designated as safety issue: No ]
- Clinical scores: KOOS, Lysholm, SF12, Knee Score [ Time Frame: Preoperatively, Postoperatively, 6 weeks, 3 months, 1 year and 2 years ] [ Designated as safety issue: No ]
- Histomorphometric evaluation of bone healing and osseous integration of cement [ Time Frame: 1 year ] [ Designated as safety issue: No ]
| Enrollment: | 45 |
| Study Start Date: | December 2004 |
| Study Completion Date: | December 2008 |
| Primary Completion Date: | June 2006 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Minced Iliac Crest autograft in osteotomysite
|
Procedure: bonesubstitution (Calcibon, Iliac Crest Bonegraft, control)
Osteotomysite are filled with Calcibon (an injectable calcium phosphate cement) or Minced Iliac Crest Bonegraft og local graft as control
|
|
Experimental: 2
Injectable calcium phosphate cement in osteotomysite
|
Procedure: bonesubstitution (Calcibon, Iliac Crest Bonegraft, control)
Osteotomysite are filled with Calcibon (an injectable calcium phosphate cement) or Minced Iliac Crest Bonegraft og local graft as control
|
|
Active Comparator: 3
Local autograft in the osteotomysite serves as control
|
Procedure: bonesubstitution (Calcibon, Iliac Crest Bonegraft, control)
Osteotomysite are filled with Calcibon (an injectable calcium phosphate cement) or Minced Iliac Crest Bonegraft og local graft as control
|
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Osteoarthritis of medial compartment of the knee, Ahlbäck gr. 1-2
- Candidate for proximal tibial medial open-wedge osteotomy
- Signed informed consent
Exclusion Criteria:
- Prednisolone treatment.
- NSAID treatment.
- BMI > or = 35.
- Previous surgery in lateral knee compartment.
- Secondary Arthrosis following fracture(s) of the tibial condyle(s).
- Lack of informed consent.
Contacts and Locations| Denmark | |
| Northern Orthopaedic Division, Klinik Farsoe, Aalborg University Hospital | |
| Farsoe, Northern Jutland, Denmark | |
| Principal Investigator: | Thomas Lind-Hansen, MD | Northern Orthopaedic Division, Denmark |
More Information
No publications provided
| Responsible Party: | Northern Orthopaedic Division, Denmark |
| ClinicalTrials.gov Identifier: | NCT00319280 History of Changes |
| Other Study ID Numbers: | ON-01-004-ML |
| Study First Received: | April 27, 2006 |
| Last Updated: | May 1, 2013 |
| Health Authority: | Denmark: The Danish National Committee on Biomedical Research Ethics |
Keywords provided by Northern Orthopaedic Division, Denmark:
|
Osteoarthritis, Knee Osteotomy Healing Roentgen Stereometric Analysis |
Additional relevant MeSH terms:
|
Osteoarthritis Osteoarthritis, Knee Arthritis |
Joint Diseases Musculoskeletal Diseases Rheumatic Diseases |
ClinicalTrials.gov processed this record on June 18, 2013